Радионуклидная диагностика для практических врачей - Лишманова Ю.Б.
ISBN 5-93629-166-9
Скачать (прямая ссылка):
95. Holman B.L., Lee R.G., Hill TD. et al. A comparison of two cerebral perfusion tracers, N-isopropyl-l-123-p-iodoamphetamine and 1-123 HIPDM in the human // J. Nucl. Med. - 1984. - Vol. 25. - P. 25-30.
96. Homan R.W., Devous M.D., Stokely E.M., Bonte F.J. Correlation of EEG findings and cerebral blood flow in patients with partial seizures // Neurology. - 1984. - Vol. 34 (Suppl. I). - P. 124.
97. Hugli O.D., Leys D., Roeisseaux M. Quantitative comparison of 99m-technetium ethyl cysteinate dimer cerebral uptake with 133-Xe regional cerebral blood flow using single photon emission computed tomography: [Pap.] Eur. Assoc. Nucl. Med. Cong., Vienna, 1-5 Sept 1991 // Eur. J. Nucl. Med. - 1991. - Vol. 18 (8). - P. 610.
98. Inoue Y., Momose T, Machida K. et al. A new method for monitoring the cerebrovascular response to acetazolamide using 99mTc-DTPA-HSA // Radiat. Med. - 1992. - Vol. 10. - P. 45-47.
99. Inoue Y, Momose T, Machida K. et al. Quantitation of cerebral blood volume by 99Tc-DTPA-HSA SPECT // Radiat. Med. - 1992. - Vol. 10. -P. 184-188.
100. Inoue Y, Momose T, Machida K., Honda N., MamiyaT. et al. An approach to cerebral vasodilatory capacity in unilateral and bilateral cerebrovascular diseases using radiolabeled human serum albumin // Clin. Nucl. Med. - 1995. - Vol. 20. - P. 340-345.
101. Inoue Y., Momose T, Machida K. et al. SPECT measurements of cerebral blood volume before and after Acetazolamide in occlusive cerebrovascular diseases И Rad. Med. - 1994. - Vol. 12. - P. 225-229.
102. Inoue Y., Momose T, Machida K. et al. Assessment of the cerebrovascular response to Acetazolamide using 99mTc-DTPA-HSA: methodological considerations// Rad. Med. - 1994. - Vol. 12. - P. 189-192.
103. Inoue Y, Momose T, Machida K. et al. Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease //J. Nucl. Med. - 1993. - Vol. 34 (1). - P. 984-986.
104. Inugami A., Kanno I., Uemura K. Linearization correction of 99mTc-labeled hexamethyl-propylene amine oxime (HM-PAO) image in terms of regional CBF distribution: comparison to Cl 502 inhalation steady - state method measured by positron emission tomography // J. Cereb. Blood Flow Metab. - 1988. - Vol. 8 (6). - P. 52-60.
105. Itoh H., Iida H., Murakami M. A technique for a rapid imaging of regional CBF and partion coefficient using dynamic SPECT and N-isopropil-p-[123l]iodoamphetamine (1231-IMP) // Kaku-lgaku. - 1993. - Vol. 30(1). - P. 13-23.
106. Jagust W.J., Budinger TF., Reed B.R. The diagnosis of dementia with single photon emission computed tomography// Arch. Neurol. - 1987. -Vol. 44. - P. 258-262.
107. JagustW.J., BudingerTF., Reed B.R. The diagnosis of dementia with single photon emission computed tomography // Arch. Neurol. - 1987. -Vol. 44. - P. 258-262.
108. Jibiki I., Matsuda H., Kido H. Quantitative assessment of regional cerebral blood flow with 1231-IMP in normal adult subjects // Acta. Neurol. Napoli.- 1993.-Vol. 15(1).-P. 7-15.
109. Jinnouchi S., Hoshi H., OhnishiT. et al. Thailium-201 SPECT for predicting histological types of meningiomas// J. Nucl. Med. - 1993. - Vol. 34. - P. 2091-2094.
110. Johnson K.A., Holman B.L, Rosen T.J. et al. Iofetaminc 1-123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease // Arch. Intern. Med. - 1990. - Vol. 150. - P. 752-756.
111. Капо I., Lassen N.L Two methods for calculating cerebral blood flow from emission computed tomography of inert gas concentrations // J. Comput. Assist. Tomography. - 1979. - Vol. 3 (1). - P. 71-76.
112. Knapp W.H., von Kummer R., Kubler W. Imaging of cerebral blood flow-to-volume distribution using SPECT//J. Nucl. Med. - 1986. - Vol. 27. -P. 465-470.
113. Kojima Y., Kuwana N., Noji M., Tosa J. Differentiation of malignant glioma and metastatic brain tumour by 201TI single photon emission computed tomography// Neurologia Medico-Chirurgica. - 1994. - Vol. 34. - P. 588-592.
114. Kuhl D.E., Barrco J.R., Huang S.C Quantifying local cerebral blood flow with N-isopropyl-p-l-123 iodoamphetamine (IMP) tomography // J. Nucl. Med. - 1982. - Vol. 23. - P. 196-203.
115. KuikkaJ.T, AkermanK.K., Bergstrom J.K. et al. lodine-123 labelled N-(2-fluoroethyl)-2b-carbomethoxy-3b-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain// EJNM. - 1995. - Vol. 22 (7). - P. 682-686.
116. KuikkaJ.T, Akerman K.K., Hiltunen J. et al. Striatal and extrastiatal imaging of dopamine D2 receptors in the living human brain with [123I] epide-pride single-photon emission tomography// EJNM. - 1997. - Vol. 24 (5). - P. 483-487.
117. Kuikka J.T1 Baulieu J.L., Hitunen J. et al. Pharmacokinetics and dosimetry of iodine-123 labelled PE21 in humens, a radioligand for dopamine transporter imaging // EJNM. - 1998. - Vol. 25 (5). - P. 531-534.
118. Kurokawa H., lino K., Kojima H., Saito H. Regional cerebral blood flow in the acute stage with ischemic cerebrovascular disease studied by xenon-133 inhalation and single photon emission computerised tomography//No To Shinkei. - 1987. - Vol. 39 (5). - P. 437-446.
